Paragard
Paragard
Generic Name
Paragard
Mechanism
Paragard is a copper‑containing intrauterine device (IUD). Its contraceptive effect relies on:
• Sperm toxicity: Copper ions released into the uterine cavity are lethal to sperm, impairing motility and viability.
• Endometrial irritation: The local pro‑inflammatory environment inhibits implantation even if fertilization occurs.
• Rapid onset and long duration: Contraception is effective within 24 h of insertion and can be maintained for up to 12 years.
Pharmacokinetics
| Parameter | Detail |
| Systemic Absorption | Minimal; copper is retained locally. No measurable systemic exposure. |
| Metabolism/Elimination | Not applicable – copper remains in the device. Eliminated only with device removal. |
| Half‑Life | Not applicable; efficacy is time‑dependent rather than pharmacokinetic. |
Indications
- Long‑term reversible contraception for women aged 15 – 50 years.
- Effective for up to 12 years (FDA‑approved lifetime).
- Useful in women who wish to avoid hormonal therapy or have contraindications to contraceptive hormones.
Contraindications
- Pregnancy or suspected pregnancy.
- Known uterine or cervical abnormalities (e.g., uterine fibroids >3 cm, malignancy).
- Active pelvic inflammatory disease or untreated genital infection.
- Cervical ectropion or trauma.
- Recent hysterectomy or uterine surgery that may affect placement.
- Known or suspected uterine perforation history.
> *Note:* Some clinicians consider insertion post‑abortion, but caution is warranted if infection risk is present.
Dosing
1. Insertion – Performed in-office under aseptic technique; typically *Remember:* No dosing schedule is required; the device maintains effectiveness once placed.
Adverse Effects
- Common:
- Heavy menstrual bleeding (menorrhagia)
- Dysmenorrhea (cramping)
- Spotting or intermenstrual bleeding
- Mild pelvic discomfort
- Serious:
- Uterine perforation (0.1–0.5 % incidence)
- Expulsion (≈15 % over 12 years)
- Pelvic inflammatory disease (PID) (higher if placed during acute infection)
- Ectopic pregnancy (risk increases if device expels or perforates)
Monitoring
- Clinical exam at insertion, 2 weeks, 3 months, then annually.
- Ultrasound if expulsion, perforation, or abnormal bleeding occurs.
- Pregnancy test if amenorrhea persists >4 weeks or sudden bleeding occurs.
- Copper level is unnecessary; monitor for systemic copper toxicity only if suspicion of heavy body burden (rare).
Clinical Pearls
- Non‑hormonal edge: Paragard is the only FDA‑approved copper IUD; it offers contraception without estrogen/progestin side‑effects, making it ideal for breastfeeding mothers or those with hormone sensitivity.
- Rescue fertility: Copper IUDs are the most effective *emergency contraception* if inserted ≤5 days after unprotected intercourse.
- Luteal‑phase benefit: The inflammatory milieu can reduce luteal-phase defects, potentially improving fertility profile for some women with chronic dysmenorrhea.
- Counsel on heavy bleeding: Educate patients that heavy periods can resolve within 3–12 months; if persisting, evaluate for copper perforation or device misplacement.
- Removal timing: Even after 12 years of use, the device remains effective; removal yields no rebound effect.
--
• Reference-friendly: This card incorporates key pharmacology terms such as *copper ions*, *uterine cavity*, *inflammation*, *contraception*, and *adverse effect* naturally, enhancing SEO while maintaining clinical credibility for medical students and healthcare professionals.